CHRISTINE COOLEY: Open Payments
NPI 1134133283 · TROY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,044 in 57 payments from 11 companies in 2025. Trend: 2023 $355 · 2024 $709 · 2025 $1,044
Food & beverage: $1,044
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 35 | $590 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $113 |
| QOL Medical, LLC | 3 | $74 |
| Janssen Biotech, Inc. | 2 | $51 |
| ABBVIE INC. | 2 | $48 |
| Ardelyx, Inc. | 2 | $46 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 3 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Gilead Sciences, Inc. | 1 | $24 |
Products named: XIFAXAN, ENTYVIO, Sucraid, TREMFYA, LINZESS, IBSRELA, REZDIFFRA, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
